In this section of the page, you will find all the information you need to understand how Moderna (MRNA) dividends work. In addition, you will be able to consult the payment date, the ex-dividend date, the last day to be entitled to the payment, the money to be received per share, the yield and any other doubts that may arise.
There is no upcoming dividend defined for Moderna.
There is no set last day on which buying Moderna shares generates the possibility of earning dividends.
There has been no final dividend for Moderna.
Moderna, listed on the American stock exchange under the ticker symbol MRNA, although to date it has not paid dividends to its shareholders and has not yet announced any change in this policy.
Join +33,000 investors who get notifications, analysis and news.
Payout Ratio Moderna Dividends
Dividend calendar of Moderna
There is no Dividend Calendar of Moderna defined for 2023.
Historical annual dividend yields of Moderna
Dividend yield of Moderna vs. the sector
Dividend yield history in Moderna
Dividend history of Moderna
Moderna has never distributed dividends, so it has an empty dividend history.
Moderna dividend capture strategy
Information about Moderna
Moderna, is a company dedicated to biotechnology and creation of drugs or vaccines based on the use of messenger RNA.
Its name is derived from the union between the words "modified" and "RNA", was founded in 2010 and begins its activities in 2011, conducted trials with other laboratories such as AstraZeneca, Mark and Alexion Pharmaceuticals, but in 2014 they decide to focus exclusively on their methodology and create vaccines based on mRNA.
In 2017 they create and commercialize the human vaccine mRNA-1653, with multivalent effect, protecting against human metapneumovirus (hMPV) and parainfluenza virus.
In 2020, because of the COVID-19 pandemic, they gained media attention by announcing that their experimental vaccine against the virus had successfully passed the first and second phase of the study by producing antibodies, although by then the possibility of generating side effects had not been controlled.
However, they were able to determine that if applied in low doses the adverse reactions (which could range from headache, fatigue, muscle pain to fever) decreased considerably, so it was studied with two doses of 100 mg administered at an interval of 29 days, obtaining approval in December of that year, being the second to be accepted worldwide.
Its headquarters are located in Massachusetts, United States, its business is mainly based on the insertion of the synthetic mRNA chain to live cells to try to reprogram them and develop an immune behavior, methodology used in previous opportunities by other laboratories, but abandoned for not being able to minimize the side effects that were generated, which is why, except for vaccines, the drugs produced by Moderna have not yet been approved to be marketed.
Frequently asked questions about Moderna dividends
Moderna is listed on the U.S. Technology Index and is part of the Nasdaq.
Moderna has the Ticker or stock code MRNA.
Moderna belongs to the Health Care sector and the Biotechnology industry.
The CEO of Moderna in 2023 is Mr. Stephane Bancel.
At this moment, the value of a Moderna share is 79.42$.
Moderna does not have a growing dividend program. Dividends have not shown a steady growth in the last 5 years.